Andrin Oswald
Directeur/Membre du Conseil chez Univercells SA
Profil
Andrin Oswald currently works at Univercells SA, as Director and Novartis Vaccines & Diagnostics Ltd., as Division Head from 2008.
Dr. Oswald also formerly worked at Novartis International AG, as Chairman & Chief Executive Officer in 2015, Speedel Holding AG, as Chief Executive Officer from 2008 to 2011, Speedel Pharma AG, as Chief Executive Officer from 2008 to 2011, Centogene NV, as Chief Executive Officer from 2020 to 2021, Novartis Institutes for Biomedical Research, Inc., as Director, Bill & Melinda Gates Foundation Trust, as Partner, Novartis AG, as Member-Management Board, McKinsey & Co., Inc., as Principal, and Novartis Pharma Schweiz AG, as Principal.
Dr. Oswald received his doctorate degree in 1999 from the University of Geneva.
Postes actifs de Andrin Oswald
| Sociétés | Poste | Début |
|---|---|---|
Novartis Vaccines & Diagnostics Ltd.
 Novartis Vaccines & Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Vaccines & Diagnostics Ltd. is a healthcare company based in Liverpool, UK that provides solutions to address the evolving needs of patients worldwide. The British company offers information and resources for healthcare professionals about Novartis medicines through the Novartis HCP Portal. Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG, one of the largest pharmaceutical companies in the world. Novartis is one of Liverpool's leading employers in the healthcare industry and has a strong history of investing in the city over the last sixty years. | Corporate Officer/Principal | 01/01/2008 |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrin Oswald
| Sociétés | Poste | Fin |
|---|---|---|
| CENTOGENE N.V. | Directeur Général | 20/12/2021 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Directeur Général | 27/07/2015 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2015 |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de Andrin Oswald
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Entreprise privées | 9 |
|---|---|
Speedel Holding AG
 Speedel Holding AG Pharmaceuticals: MajorHealth Technology Speedel Holding operates as a holding company with interests in pharmaceutical manufacturing. The company was founded on July 19, 2000 and is headquartered in Basel, Switzerland. | Health Technology |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Vaccines & Diagnostics Ltd.
Novartis Vaccines & Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Vaccines & Diagnostics Ltd. is a healthcare company based in Liverpool, UK that provides solutions to address the evolving needs of patients worldwide. The British company offers information and resources for healthcare professionals about Novartis medicines through the Novartis HCP Portal. Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG, one of the largest pharmaceutical companies in the world. Novartis is one of Liverpool's leading employers in the healthcare industry and has a strong history of investing in the city over the last sixty years. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Finance |
Univercells SA
Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Health Technology |
